Ultra-rapid Lispro (URLi) Reduces Postprandial Glucose Excursions vs. Humalog ® in Patients with T2D at Multiple Meal-to-Dose Timing Intervals

Category Primary study
Conference78th Scientific Sessions of the American Diabetes Association, ADA 2018
Year 2018
This article has no abstract
Epistemonikos ID: b9f85ed5bf12084f3073fa3c413434a59d231b8d
First added on: Apr 04, 2026